SCHEMBL5589024

SCHEMBL5589024

CC(=Nc1c(C(C)C)cc(C)cc1C(C)C)c1cccc(C(C)=Nc2c(C(C)C)cc(C)cc2C(C)C)n1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 2/20 0.33
GABRG2 P18507 2/20 0.33
GABRB3 P28472 2/20 0.33
HSP90AA1 P07900 1/20 0.33
LMNA P02545 3/20 0.33
SLC6A2 P23975 2/20 0.33
HTR2B P41595 2/20 0.33
TRPA1 O75762 1/20 0.33
CHRM1 P11229 1/20 0.33
ADRA1A P35348 1/20 0.33
HPGD P15428 2/20 0.32
CYP1A2 P05177 2/20 0.32
FAAH O00519 1/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
CYP3A4 P08684 1/20 0.32
TSHR P16473 1/20 0.32
GABRB1 P18505 1/20 0.32
PTGS1 P23219 1/20 0.32
HTR2C P28335 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6910795 1.00 GABRA1 (0.33) GABRA1GABRG2GABRB3HSP90AA1LMNA
SCHEMBL5590045 0.98 GABRA1 (0.33) GABRA1GABRG2GABRB3HSP90AA1LMNA
Hydrochloric Acid SCHEMBL7180672 0.97 GABRA1 (0.32) GABRA1GABRG2GABRB3HSP90AA1LMNA
Hydrochloric Acid SCHEMBL7178317 0.97 GABRA1 (0.32) GABRA1GABRG2GABRB3HSP90AA1LMNA
Hydrochloric Acid SCHEMBL7176931 0.97 GABRA1 (0.32) GABRA1GABRG2GABRB3HSP90AA1LMNA
Hydrochloric Acid SCHEMBL7175518 0.97 GABRA1 (0.32) GABRA1GABRG2GABRB3HSP90AA1LMNA
Hydrochloric Acid SCHEMBL7174370 0.97 GABRA1 (0.32) GABRA1GABRG2GABRB3HSP90AA1LMNA
Hydrochloric Acid SCHEMBL7176822 0.97 GABRA1 (0.32) GABRA1GABRG2GABRB3HSP90AA1LMNA
SCHEMBL16999963 0.93 GABRA1 (0.37) GABRA1LMNAGABRB1MEN1KMT2A
SCHEMBL6912475 0.92 NOS3 (0.33) GABRA1HSP90AA1LMNAHPGDGABRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7247687-B2 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-07-24 US disclosed
EP-1521758-B1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2006-05-24 EP disclosed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 US disclosed
WO-2004074333-A2 PROCESS FOR HOMO- OR COPOLYMERIZATIONOF CONJUGATED OLEFINES DOW GLOBAL TECHNOLOGIES INC. (US) 2004-09-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization MLX, LOX, LMTK3 GABRA1 3688/4885GABRG2 3901/4885GABRB3 3425/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.